This is a preview of subscription content, log in via an institution to check access.
Notes
The meeting was held 1–5 April in Washington, D.C., USA.
Cancer recurrence was defined in this study as a rise in prostate-specific antigen levels after surgery.
Micro-RNAs are ‘tiny snippets’ of single-stranded RNA that can regulate the expression of genes, and thus regulate protein synthesis that affects cellular pathways.
References
Epigenomics. Clinical study proves prognostic power of Epigenomics’ biomarker in prostate cancer. Media release: 5 Apr 2006
Epigenomics. Epigenomics confirms lead marker for prediction of breast cancer relapse. Media release: 10 Mar 2006
Epigenomics. Epigenomics presents data confirming screening for methylated DNA in blood as key to early colorectal cancer detection. Media release: 4 Apr 2006
University of Pittsburgh Medical Center. Multimarker assay for ovarian cancer most promising to date. Media release: 2 Apr 2006
University of South Florida. Researchers working on better method of detecting ovarian cancer. Media release: 3 Apr 2006
American Association for Cancer Research. Markers of gene, protein, or micro-RNA activity predict outcome in cancers. Media release: 28 Mar 2006
ExonHit Therapeutics. ExonHit and bioMérieux reach an important research milestone in the molecular detection of breast cancer from blood samples. Media release: 29 Mar 2006
Rights and permissions
About this article
Cite this article
Diagnostic Developments. Pharmaceutical & Diagnostic Innovation 4, 17–19 (2006). https://doi.org/10.1007/BF03257064
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03257064